ABSTRACT
Cytomegalovirus (CMV) encephalitis most commonly occurs in patients with advanced human immunodeficiency virus infection and profound CD4 cell depletion and is rare in transplant recipients. We describe a patient with pathologically proven CMV ventriculoencephalitis that occurred after human herpesvirus-6 limbic encephalitis, following reduced-intensity conditioning cord blood transplantation (CBT). At approximately day 150 after CBT, the patient became acutely confused after steroid therapy for grade III acute graft-versus-host disease. Fluid-attenuated inversion recovery magnetic resonance imaging of the brain revealed a communicating hydrocephalus with abnormal periventricular hyperintensity. Neuropathologic examination of the brain at autopsy revealed necrotizing CMV ventriculoencephalitis, limbic encephalitis, and multifocal necrotizing leukoencephalopathy. This case represents the first report of CMV encephalitis following CBT and serves to highlight the interrelationship between viruses in transplant recipients.
Subject(s)
Cord Blood Stem Cell Transplantation/adverse effects , Cytomegalovirus Infections/etiology , Encephalitis, Viral/etiology , Transplantation Conditioning , Cerebral Ventricles/pathology , Cytomegalovirus Infections/pathology , Encephalitis, Viral/pathology , Female , Humans , Middle AgedABSTRACT
Orthotopic implantation of a metastatic cell line of Lewis lung carcinoma (LLC-MLN), which was isolated by an in vivo selection method, resulted in greater metastatic growth in mediastinal lymph nodes as compared with that of the original LLC cells. LLC-MLN cells also had increased invasive ability and activator protein-1 (AP-1) transcriptional activity as compared with the original LLC cells. This is well consistent with the previously reported finding that overexpression of AP-1 is associated with lymphatic metastasis in lung cancer patients. Oral administration of curcumin, which downregulates AP-1 transcription, significantly inhibited the mediastinal lymph node metastasis of orthotopically implanted LLC cells in a dose-dependent manner, but did not affect the tumor growth at the implantation site. Combined treatment with curcumin and an anti-cancer drug, cis-diamine-dichloroplatinum (CDDP), resulted in a marked inhibition of tumor growth at the implanted site and of lymphatic metastasis, and a significant prolongation of the survival time. The downregulation of transcriptional AP-1 activity by curcumin as seen in the dual luciferase assay caused inhibition of LLC cell invasion through the repression of expression of the mRNAs for urokinase-type plasminogen activator (u-PA) and its receptor (u-PAR). Inhibition of AP-1 transcriptional activity may offer improved therapeutic efficacy for lung cancer patients with lymphatic metastasis.
Subject(s)
Carcinoma, Lewis Lung/metabolism , Carcinoma, Lewis Lung/secondary , Lung Neoplasms/metabolism , Mediastinal Neoplasms/secondary , Transcription Factor AP-1/metabolism , Animals , Antineoplastic Agents/pharmacology , Carcinoma, Lewis Lung/genetics , Cell Division/drug effects , Cisplatin/pharmacology , Curcumin/pharmacology , Dose-Response Relationship, Drug , Female , Kinetics , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Lymphatic Metastasis , Mediastinal Neoplasms/pathology , Mice , Mice, Inbred C57BL , Neoplasm Invasiveness , RNA, Neoplasm/biosynthesis , Receptors, Cell Surface/biosynthesis , Receptors, Cell Surface/genetics , Receptors, Urokinase Plasminogen Activator , Urokinase-Type Plasminogen Activator/biosynthesis , Urokinase-Type Plasminogen Activator/geneticsABSTRACT
We examined the effect of berberine, a major component with anti-fungal properties contained in Coptidis Rhizoma and Phellodendri Cortex, on the lymph node metastasis of murine lung cancer. Oral administration of berberine for 14 days significantly inhibited the spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma (LLC) into the lung parenchyma in a dose-dependent manner, but did not affect the tumor growth at the implantation site of the lung. Combined treatment with berberine and an anti-cancer drug, CPT-11, resulted in a marked inhibition of tumor growth at the implantation site and of lymphatic metastasis, as compared with either treatment alone. Anti-activator protein-1 (anti-AP-1) transcriptional activity of non-cytotoxic concentrations of berberine caused the inhibition of the invasiveness of LLC cells through the repression of expression of urokinase-type plasminogen activator (u-PA).
Subject(s)
Berberine/therapeutic use , Camptothecin/analogs & derivatives , Carcinoma, Lewis Lung/secondary , Lung Neoplasms/pathology , Mediastinal Neoplasms/prevention & control , Animals , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Camptothecin/therapeutic use , Carcinoma, Lewis Lung/prevention & control , Disease Models, Animal , Female , Irinotecan , Lung Neoplasms/prevention & control , Lymphatic Metastasis , Mice , Mice, Inbred C57BL , Neoplasm Invasiveness/prevention & control , Neoplasm Transplantation , Transcription Factor AP-1/antagonists & inhibitorsABSTRACT
Cytochrome P450 (CYP)-dependent drug metabolism decreases in vivo and in cultured hepatocytes under various immunostimulatory conditions. Nitric oxide (NO) released during inflammation is presumed to be involved in this phenomenon. CYP3A4, which is abundant in the liver and small intestine and participates in the metabolism of various drugs, is known to be induced by 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) in the colon carcinoma cell line Caco-2. In this study we examined whether NO affected CYP3A4 gene expression induced by 1,25(OH)2D3 in Caco-2 cells. Induction of CYP3A4 mRNA by 1,25(OH)2D3 was suppressed in a dose-dependent manner by treatment with the NO donors NOR-4 (15-500 microM) or S-nitroso-N-acetylpenicillamine (30 microM-1 mM), which spontaneously release NO. These results indicated that NO has an inhibitory effect on the induction of CYP3A4 mRNA by 1,25(OH)2D3 in Caco-2 cells. Treatment with the guanylate cyclase inhibitor ODQ failed to prevent the inhibition of induction of CYP3A4 mRNA by 1,25(OH)2D3. 8-Bromo cGMP had no effect on 1,25(OH)2D3-induced CYP3A4 gene expression. Therefore, the suppression of CYP3A4 mRNA by NO might be mediated through a guanylate cyclase-independent pathway.
Subject(s)
Caco-2 Cells/enzymology , Calcitriol/pharmacology , Cytochrome P-450 Enzyme System/genetics , Gene Expression/drug effects , Mixed Function Oxygenases/genetics , Nitric Oxide/pharmacology , RNA, Messenger/biosynthesis , Cytochrome P-450 CYP3A , Drug Stability , Enzyme Inhibitors/pharmacology , Guanylate Cyclase/antagonists & inhibitors , Humans , Oxadiazoles/pharmacology , Quinoxalines/pharmacologyABSTRACT
Secondary amyloidosis frequently involves the gastrointestinal tract and may result in ulceration, hemorrhage, and protein-losing enteropathy. We report a patient with severe hypoalbuminemia in whom endoscopy revealed widespread ulceration of the small intestine. The protein-losing site was detected by 99mTc-diethylene triamine pentaacetic acid human serum albumin (99mTc HSA-D) scintigraphy. This evidence suggests that the ulcers and mucosal lesions associated with amyloidosis contribute to abnormal protein loss from the gastrointestinal tract.
Subject(s)
Amyloidosis/complications , Protein-Losing Enteropathies/diagnostic imaging , Technetium Tc 99m Aggregated Albumin , Technetium Tc 99m Pentetate , Aged , Female , Gastrointestinal Hemorrhage/diagnostic imaging , Gastrointestinal Hemorrhage/etiology , Humans , Protein-Losing Enteropathies/etiology , Radionuclide ImagingABSTRACT
Gastroduodenal involvement by Crohn's disease is relatively rare and occasionally causes pyloric stenosis, for which medical therapy may be ineffective and surgery may be required. We report on a 44-year-old man patient in whom corticosteroids had a marked effect in reducing pyloric stenosis caused by Crohn's disease. A proton-pump inhibitor was not effective, and Helicobacter pylori was negative.
Subject(s)
Crohn Disease/diagnosis , Pyloric Stenosis/etiology , Adult , Crohn Disease/complications , Crohn Disease/pathology , Diagnosis, Differential , Humans , Male , Pyloric Stenosis/pathologyABSTRACT
We examined the anti-metastatic effect of a newly developed inhibitor of synthetic matrix metalloproteinase (MMP), ONO-4817, on experimental pulmonary metastasis of murine renal cell carcinoma (Renca) cells and on tumor cell invasion, through reconstituted basement membrane (Matrigel) in vitro using the same cells. Oral administration of ONO-4817 (50-200 mg/kg/day) to Renca-bearing mice resulted in a dose-dependent inhibition of lung metastasis without a loss of body weight. ONO-4817 at the high dose of 200 mg/kg showed a tendency to prolong the survival of the mice. We also found that oral administration of ONO-4817 significantly inhibited the angiogenic response (number of vessels oriented towards the tumor mass) and the growth of tumors inoculated i.d. in syngeneic mice. In addition, ONO-4817, at non-cytotoxic concentrations of less than 10 microM, caused a marked inhibition of the invasion of Renca cells as compared to the vehicle control. Gelatin zymography revealed that ONO-4817 inhibited the enzymatic activity of MMP-2 produced by Renca cells in a concentration-dependent manner. In conclusion, ONO-4817 effectively inhibited lung metastasis of Renca cells through its anti-invasive and anti-angiogenic properties. These results suggest that use of the MMP inhibitor (MMPI) ONO-481 7 may provide a therapeutic basis for preventing lung recurrence and metastasis of renal cell carcinoma.
Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Renal Cell/prevention & control , Carcinoma, Renal Cell/secondary , Kidney Neoplasms/drug therapy , Lung Neoplasms/prevention & control , Lung Neoplasms/secondary , Phenyl Ethers/pharmacology , Protease Inhibitors/pharmacology , Animals , Carcinoma, Renal Cell/drug therapy , Cell Adhesion/drug effects , Cell Division/drug effects , Cell Movement/drug effects , Female , Kidney Neoplasms/pathology , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase Inhibitors , Mice , Mice, Inbred BALB C , Neovascularization, Pathologic/prevention & controlABSTRACT
Several studies have shown that the Kampo medicine Juzen-taiho-to (Si-Quan-Da-Bu-Tang in Chinese) has various biological activities, including anti-tumor effects when combined with surgical excision or with chemotherapeutic drugs. Here we investigated the effect of combined therapy with interferon (IFN)-alpha A/D and Juzen-taiho-to on experimental lung metastasis of murine renal cell carcinoma (Renca) cells. Five consecutive administrations of IFN-alpha A/D to Renca-bearing mice resulted in dose-dependent inhibition of lung metastasis. IFN-alpha A/D at the dose of 100,000 IU/mouse significantly inhibited the metastasis, but a marked loss of body weight was observed during and after the administration. In contrast, oral administration of Juzen-taiho-to (50 mg/mouse) alone tended to inhibit the metastasis, but the effect was not statistically significant. The combination treatment of suboptimal doses of IFN-alpha A/D and Juzen-taiho-to markedly augmented the antimetastatic effect without causing any loss of body weight, as compared with either treatment alone. Similar results were also obtained by treatment with IFN-gamma in combination with Juzen-taiho-to. Clinically, immunotherapy with IFNs has been primarily approved for the treatment of patients with metastatic renal cell carcinoma, but sufficient efficacy has not yet been obtained. Therefore, the combination of IFNs with Juzen-taiho-to may provide a means to increase the therapeutic potential of IFNs and to decrease their toxicity for the treatment of metastatic renal cell carcinoma.
Subject(s)
Adjuvants, Immunologic/therapeutic use , Antineoplastic Agents/therapeutic use , Carcinoma, Renal Cell/drug therapy , Drugs, Chinese Herbal/therapeutic use , Interferon Type I/therapeutic use , Kidney Neoplasms/drug therapy , Lung Neoplasms/secondary , Animals , Carcinoma, Renal Cell/physiopathology , Disease Models, Animal , Drug Therapy, Combination , Female , Injections, Intravenous , Interferon-alpha , Kidney Neoplasms/physiopathology , Lung , Lung Neoplasms/prevention & control , Medicine, Kampo , Mice , Mice, Inbred BALB C , Neoplasm Metastasis , Recombinant Fusion Proteins/therapeutic use , Recombinant ProteinsABSTRACT
The absorption, excretion, and metabolism of a single oral dose of suxibuzone, a new nonsteroidal anti-inflammatory agent, in healthy male volunteers were compared with those of phenylbutazone. After oral administration of either suxibuzone or phenylbutazone, phenylbutazone, oxyphenbutazone, and gamma-hydroxyphenylbutazone were found in the plasma; phenylbutazone was the main metabolite of suxibuzone and phenylbutazone. In the urine, p-gamma-dihydroxyphenylbutazone and several glucuronide conjugates also were found. Spectrometric and/or enzymatic analysis showed that these glucuronide conjugates were suxibuzone glucuronide, 4-hydroxymethylphenylbutazone glucuronide, 4-hydroxymethyloxyphenbutazone glucuronide, oxyphenbutazone glucuronide, and phenylbutazone glucuronides (two types: O-glucuronide and C-4-glucuroxide) after suxibuzone administration, and oxyphenbutazone glucuronide and phenylbutazone glucuronide after phenylbutazone administration. The conjugates specific to suxibuzone administration, suxibuzone glucuronide, 4-hydroxymethylphenylbutazone glucuronide, and 4-hydroxymethyloxyphenbutazone glucuronide, were excreted in the first 6 hr urine. These findings and the pharmacokinetics of these metabolites in the plasma and urine show that suxibuzone is a prodrug of phenylbutazone.
Subject(s)
Phenylbutazone/analogs & derivatives , Phenylbutazone/metabolism , Adult , Biotransformation , Feces/analysis , Humans , Intestinal Absorption , Kinetics , Male , Time FactorsABSTRACT
We investigated the antifatigue effect of royal jelly (RJ), which had been stored at -20 degrees C from immediately after collection, in male Std ddY mice. The mice were accustomed to swimming in an adjustable-current swimming pool, then subjected to forced swimming five times during 2 wk, and the total swimming period until exhaustion was measured. They were separated into three groups with equal swimming capacity, which were administered RJ, RJ stored at 40 degrees C for 7 d (40-7d RJ), or the control solution including casein, cornstarch, and soybean oil before swimming. All mice were forced to swim for 15 min once; then the maximum swimming time to fatigue was measured after a rest period. The swimming endurance of the RJ group significantly increased compared with those of the other groups. The mice in the RJ group showed significantly decreased accumulation of serum lactate and serum ammonia and decreased depletion of muscle glycogen after swimming compared with the other groups, whereas there was no significant difference between the 40-7d RJ group and the control group in these parameters after swimming. A quantitative analysis of constituents in RJ showed that 5 7-kDa protein, which we previously identified as a possible freshness marker of RJ, was specifically degraded in RJ stored at 40 degrees C for 7 d, whereas the contents of various vitamins, 10-hydroxy-2-decenoic acid, and other fatty acids in RJ were unchanged. These findings suggest that RJ can ameliorate the physical fatigue after exercise, and this antifatigue effect of RJ in mice seems to be associated with the freshness of RJ, possibly with the content of 5 7-kDa protein.
Subject(s)
Fatigue/diet therapy , Fatty Acids/administration & dosage , Nuclear Proteins/analysis , Physical Endurance/physiology , Animals , Antigens, Nuclear , Male , Mice , Swimming/physiologyABSTRACT
This research examined family caregivers' attitudes toward their elderly relatives living with dementia. A convenience sample of fifty-nine Japanese caregivers was used. Caregiver attitudes were investigated multi-dimensionally (negative attitude, attitude of acceptance, and attitude of active interaction) using a questionnaire developed specifically for this study. The dimensions did not correlate with one another but were associated with different caregiver/elderly characteristics: i.e., negative attitude with short stay use, length of time caregivers and elderly relatives were living together and problem behaviors; attitude of acceptance with sleeping pill use and the type of relationship; and attitude of active interaction with dementia diagnosis. The results have implications for nurses in facilitating constructive caregiver attitudes.
Subject(s)
Attitude , Caregivers/psychology , Dementia , Family/psychology , Aged , Aged, 80 and over , Female , Humans , Japan , Male , Middle Aged , Statistics, NonparametricABSTRACT
The Japanese serow, Capricornis crispus (Bovidae, Caprinae, Rupicaprini), is parasitized by five Cercopithifilaria species: C. shohoi, recently described, and reexamined in this paper, C. multicauda n. sp., C. minuta n. sp., C. tumidicervicata n. sp., and C. bulboidea n. sp. Coinfections are frequent. The location (skin or subcutaneous regions) in the host of adult worms differed between the species, as did many morphological characters of both adults and microfilariae. The location (limbs, trunk, etc.) in the host of adult worms and dermal microfilariae seemed to differ depending on the species. Male and female worms of the same species had similar head shapes, buccal capsules, and, in four species, swellings in the anterior region of the body (because of the presence of a giant ventral pseudocoelomocyte). The Cercopithifilaria spp. from C. crispus were related to the primitive forms of the genus, parasites of Bovidae and Cervidae, presently recorded in Africa and Europe. C. bulboidea was particularly close to the most primitive species, C. ruandae and C. dermicola, in Africa, with the pairs of caudal papillae numbered 8 and 9 being distant from each other, but the species also had several specialized characters. Like C. rugosicauda in a European cervid, the four other species had pairs 8 and 9 close to each other; they reflect an evolutionary trend (hypertrophy of pair 6, and reduction and posterior migration of pair 7) that suggests diversification in the host.
Subject(s)
Filarioidea/classification , Goats/parasitology , Animals , Ecosystem , Female , Filariasis/parasitology , Filariasis/veterinary , Filarioidea/isolation & purification , Filarioidea/ultrastructure , Geography , Goat Diseases/parasitology , Japan , Male , Microscopy, Electron, ScanningABSTRACT
A case of chondrosarcoma of the thoracic vertebra in a 47-year-old female is described. Chest X-ray, CT and MRI disclosed an abnormal mass lesion in the posterior mediastinum. The lesion was surgically removed through right thoracotomy. The operative findings revealed that the lesion, hard and measuring 6.5 x 4.5 x 4.5 cm in diameter, was originated from the 7th and 8th thoracic vertebra. The lesion was histopathologically diagnosed chondrosarcoma. The chondrosarcoma arising from the thoracic vertebra is very rare, and only 10 cases have hitherto been reported in the Japanese literature.
Subject(s)
Chondrosarcoma/surgery , Spinal Neoplasms/surgery , Thoracic Vertebrae , Female , Humans , Middle AgedABSTRACT
Recently, cases of postoperative chylothorax have increased concomitantly with the increase in number of aggressive thoracic surgery. Chylothorax was complicated on the 6 th postoperative day in a 69-year-old male who underwent right lower lobectomy with mediastinal lymph node dissection for adenocarcinoma of the lung. After the leaking point from thoracic duct was confirmed by lymphangiography and chest CT, OK-432 1.5 KE was instilled into the intrapleural space through a intrathoracic tube. By this procedure, the chylous fistulas were completely cured. Application of OK-432, even in such a small dose as 1.5 KE, appeared very useful for the treatment of postoperative chylothorax.
Subject(s)
Chylothorax/therapy , Picibanil/therapeutic use , Pneumonectomy/adverse effects , Adenocarcinoma/surgery , Aged , Chylothorax/etiology , Humans , Instillation, Drug , Lung Neoplasms/surgery , Male , Picibanil/administration & dosage , PleuraABSTRACT
A 45-year-old male with pulmonary blastoma was described. The patient suffered from headache and gait disturbance, and was diagnosed metastatic brain tumor. The histopathology of the removed tumor indicated metastasis from pulmonary blastoma. The pulmonary tumor, which had been detected on the chest x-ray film but misdiagnosed tuberculous lesion, was subsequently diagnosed pulmonary blastoma by TBLB. The patient underwent left upper lobectomy with mediastinal lymph node dissection, but died 12 months after the operation. To our knowledge, only 54 cases with pulmonary blastoma have hitherto been reported in the Japanese literature.